PAMELA SNYDER: Open Payments
NPI 1477029445 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 87 payments from 17 companies in 2025. Trend: 2023 $835 · 2024 $1,868 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $314 |
| Novo Nordisk Inc | 15 | $252 |
| Lilly USA, LLC | 9 | $152 |
| PFIZER INC. | 11 | $149 |
| ABBVIE INC. | 9 | $149 |
| Phathom Pharmaceuticals, Inc. | 7 | $123 |
| Astellas Pharma US Inc | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Amgen Inc. | 3 | $45 |
Products named: AIRSUPRA, VOQUEZNA, JARDIANCE, Wegovy, NURTEC ODT, Ozempic, MOUNJARO, Veozah.
Industry payments across TX — which companies pay providers there.
